Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS)
CNY 52.95
(-0.11%)
CNY 52.95
(-0.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 189.66 Million CNY | 47.15% |
| 2022 | 124.85 Million CNY | -2.7% |
| 2021 | 128.31 Million CNY | -10.78% |
| 2020 | 143.81 Million CNY | 112.09% |
| 2019 | 67.8 Million CNY | 115.71% |
| 2018 | 31.43 Million CNY | -44.46% |
| 2017 | 56.59 Million CNY | 179.98% |
| 2016 | -70.76 Million CNY | -133.1% |
| 2015 | -30.35 Million CNY | -17.24% |
| 2014 | -25.89 Million CNY | -56.95% |
| 2013 | -16.49 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 80.62 Million CNY | 24.12% |
| 2024 Q3 | 130.51 Million CNY | -27.49% |
| 2024 Q2 | 180 Million CNY | 123.26% |
| 2023 Q4 | 64.95 Million CNY | -2.92% |
| 2023 FY | 183.72 Million CNY | 47.15% |
| 2023 Q1 | 29.11 Million CNY | -64.18% |
| 2023 Q2 | 25.05 Million CNY | -13.95% |
| 2023 Q3 | 66.9 Million CNY | 167.07% |
| 2022 Q4 | 81.26 Million CNY | 1812.57% |
| 2022 FY | 124.85 Million CNY | -2.7% |
| 2022 Q2 | 19.85 Million CNY | 29.93% |
| 2022 Q1 | 15.27 Million CNY | -64.5% |
| 2022 Q3 | 4.24 Million CNY | -78.6% |
| 2021 FY | 128.31 Million CNY | -10.78% |
| 2021 Q4 | 43.04 Million CNY | 72.83% |
| 2021 Q2 | 13.57 Million CNY | -71.0% |
| 2021 Q3 | 24.9 Million CNY | 83.51% |
| 2021 Q1 | 46.79 Million CNY | -2.76% |
| 2020 Q1 | 223.56 Thousand CNY | -98.1% |
| 2020 Q4 | 48.12 Million CNY | 18.79% |
| 2020 FY | 143.81 Million CNY | 112.09% |
| 2020 Q2 | 54.75 Million CNY | 24392.91% |
| 2020 Q3 | 40.51 Million CNY | -26.02% |
| 2019 Q3 | 18.68 Million CNY | 60.35% |
| 2019 FY | 67.8 Million CNY | 115.71% |
| 2019 Q4 | 11.74 Million CNY | -37.13% |
| 2019 Q2 | 11.65 Million CNY | 55.53% |
| 2019 Q1 | 7.49 Million CNY | 132.86% |
| 2018 Q4 | -22.8 Million CNY | -345.67% |
| 2018 FY | 31.43 Million CNY | -44.46% |
| 2018 Q1 | -347.69 Thousand CNY | -101.55% |
| 2018 Q2 | 45.3 Million CNY | 13130.21% |
| 2018 Q3 | 9.28 Million CNY | -79.51% |
| 2017 Q3 | 19.26 Million CNY | -25.2% |
| 2017 FY | 56.59 Million CNY | 179.98% |
| 2017 Q1 | -450.56 Thousand CNY | 98.29% |
| 2017 Q4 | 22.41 Million CNY | 16.37% |
| 2017 Q2 | 25.75 Million CNY | 5816.9% |
| 2016 Q2 | -7.82 Million CNY | 0.0% |
| 2016 Q4 | -26.42 Million CNY | 0.0% |
| 2016 Q3 | -26.42 Million CNY | -237.57% |
| 2016 Q1 | -7.82 Million CNY | -10.44% |
| 2016 FY | -70.76 Million CNY | -133.1% |
| 2015 Q1 | -5.62 Million CNY | 0.0% |
| 2015 Q2 | -5.62 Million CNY | 0.0% |
| 2015 Q4 | -7.08 Million CNY | 0.0% |
| 2015 FY | -30.35 Million CNY | -17.24% |
| 2015 Q3 | -7.08 Million CNY | -25.91% |
| 2014 FY | -25.89 Million CNY | -56.95% |
| 2013 FY | -16.49 Million CNY | 0.0% |